Rps17 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ribosomal Protein S17 (RPS17) is a component of the 40S ribosomal subunit and plays essential roles in protein synthesis. RPS17 is located on the head of the small ribosomal subunit and participates in mRNA binding and decoding. Beyond its fundamental role in translation, RPS17 has been implicated in various cellular processes that may be relevant to neurodegenerative diseases, including ribosome biogenesis, cell proliferation, and apoptosis.
RPS17 is a 40S ribosomal protein encoded by the RPS17 gene. It belongs to the ribosomal protein S17 family.
- Molecular Weight: Approximately 15.5 kDa
- Amino Acids: 135 amino acids
- Isoforms: Multiple isoforms through alternative splicing
- Subcellular Localization: Cytoplasmic, associated with the 40S ribosomal subunit
- Domain Structure: Contains S17 domain involved in RNA binding
RPS17 contributes to the function of the 40S ribosomal subunit:
- mRNA Binding: RPS17 participates in mRNA binding and positioning on the ribosome
- Decoding Center: Located near the decoding center, contributes to codon-anticodon recognition
- Translation Initiation: Essential for initiation complex formation
- Reading Frame Maintenance: Helps maintain reading frame during translation elongation
- 40S Assembly: RPS17 is incorporated into the developing 40S subunit
- Pre-rRNA Processing: Interacts with processing factors in ribosome biogenesis
¶ Translation Defects and Neurodegeneration
Dysregulated translation is increasingly recognized in neurodegenerative diseases. RPS17 may contribute through:
- Global Translation Deficits: Reduced translation capacity affects protein homeostasis
- Selective Translation: Some mRNAs may be more affected by ribosomal defects
- Synaptic Translation: Local translation at synapses is crucial for neuronal function
RPS17 may be relevant to Alzheimer's disease through:
- Amyloid Effects: Amyloid-β may affect ribosomal function
- Tau Pathology: Pathological tau affects translation machinery
- Synaptic Protein Loss: RPS17 dysfunction may reduce synaptic protein synthesis
- Ribosomal Stall: Aβ causes ribosomal stalling on specific transcripts
- Long Potentiation: Translation regulation crucial for memory
The " translational collapse" hypothesis:
- Ribosomes isolated from AD brain show reduced activity
- Specific mRNAs affected more than others
- Synaptic mRNAs particularly vulnerable
- Recovery possible with intervention
In Parkinson's disease:
- Mitochondrial Function: Translation of mitochondrial proteins may be affected
- Alpha-Synuclein: Altered translation rates may affect protein aggregation
- Neuronal Survival: Protein synthesis is crucial for neuron survival
DDX17 interacts with LRRK2, the most common PD-associated kinase:
- Kinase regulation: DDX17 modulates LRRK2 activity
- Substrate targeting: May serve as LRRK2 substrate
- Pathogenic pathways: LRRK2-mediated phosphorylation altered
¶ Ribosomopathies and Neurodegeneration
RPS17 mutations are associated with Diamond-Blackfan anemia (DBA), a pure red cell aplasia. While not directly a neurodegenerative disease, DBA demonstrates the importance of ribosomal proteins in cellular function.
Ribosomal defects may cause neurodegeneration through:
- p53 activation: Ribosomal stress activates p53
- Selective vulnerability: Neurons particularly sensitive
- Protein homeostasis: Impaired translation affects proteostasis
- Cellular stress: Combined with other stressors
| Variant |
Disease |
Effect |
Notes |
| RPS17 |
Diamond-Blackfan anemia |
ribosomal dysfunction |
Hematopoietic |
| RPS17 |
MDS |
Splicing defects |
Clonal |
| RPS17 |
dAD |
not determined |
Research |
- Missense mutations in DBA
- Splice site variants
- Frameshift variants reported
RPS17 location:
- 40S subunit head
- Near mRNA channel
- Contact with 18S rRNA
- Protein-protein interactions
| Partner |
Interaction |
Function |
| RPS3 |
Complex |
Translation |
| RPS14 |
Complex |
Decoding |
| RPS19 |
Complex |
Assembly |
| 18S rRNA |
Binding |
Structure |
| Approach |
Strategy |
Status |
| Ribosome enhancers |
Increase activity |
Research |
| Translation modulators |
Target specific mRNAs |
Research |
| Gene therapy |
Restore expression |
Preclinical |
Current research areas include:
- Ribosome profiling: Identify translational changes
- Mechanism studies: Elucidate RPS17-neurodegeneration links
- Therapeutic development: Identify druggable targets
- Biomarkers: RPS17 as disease biomarker
- Model systems: Develop better cellular models
- Ribosome-Targeted Therapies: Understanding RPS17 function may reveal therapeutic approaches
- Ribosome Biogenesis: May reveal vulnerabilities in specific cell types